Both in Pharmaceuticals
Acadia Pharmaceuticals vs Amylyx Pharmaceuticals
Over the past year ACAD returned −8.0% and AMLX returned +114.7%; their daily moves had a correlation of 0.32.
ACAD −8.0% AMLX +114.7%Growth of $1, one year, split-adjusted
| Metric | ACAD | AMLX |
|---|---|---|
| Price | $20.57 | $29.20 |
| Market cap | $3.54B | $3.66B |
| Today | +0.49% | +4.14% |
| 1 month | +2.3% | +5.1% |
| 6 months | −8.0% | +77.7% |
| Year to date | −23.0% | +141.7% |
| 1 year | −9.4% | +109.6% |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.3× | — |
| Price / sales | 3.1× | — |
| Net cash | $956.5M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 112.5% |
| Short % of float | 7.1% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).